Obstructive Sleep Apnea and Endothelial Function in Patients With Resistant Hypertension
Evaluation of Obstructive Sleep Apnea and Endothelial Function in Resistant Hypertension Patients
1 other identifier
observational
40
1 country
1
Brief Summary
The purpose of this study is to determine the prevalence of obstructive sleep apnea and associate it with the endothelial function behavior in patients with resistant hypertension. Two groups will be evaluate, one presenting uncontrolled high blood pressure, and other, with controlled blood pressure by drugs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 12, 2013
CompletedFirst Posted
Study publicly available on registry
May 15, 2013
CompletedMay 15, 2013
February 1, 2013
6 months
May 12, 2013
May 12, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of obstructive sleep apnea
6 months
Study Arms (2)
Resistant hypertension
Patients with uncontrolled blood pressure despite 3 medications, including diuretic. Endothelial function assessed by peripheral arterial tonometry (PAT) by EndoPAT and the OSA diagnosis also through PAT, using the portable device WatchPAT.
Controlled hypertension
Patients with controlled blood pressure by medications. These drugs are the same used in both groups.
Interventions
BP was measured by oscillometric method on automatic device. Endothelial function was assessed by peripheral arterial tonometry (PAT) by EndoPAT2000® and the OSA diagnosis also through PAT, using the portable device WatchPAT200®. Anthropometric evaluation was performed through measurements of waist, hip and neck circumference, body mass index, waist to height ratio (WHtR), and body composition assessed by bioelectrical impedance.
Eligibility Criteria
Hypertensive patients, from the Hypertension Clinic of UERJ
You may qualify if:
- ages between 18 and 75 years
- previous hypertension diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pedro Ernesto University Hospital
Rio de Janeiro, Rio de Janeiro, 20.551-030, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio F Sanjuliani, MD, ScD
Rio de Janeiro State University - Brazil
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor / Professor
Study Record Dates
First Submitted
May 12, 2013
First Posted
May 15, 2013
Study Start
July 1, 2012
Primary Completion
January 1, 2013
Study Completion
May 1, 2013
Last Updated
May 15, 2013
Record last verified: 2013-02